ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
6 announcements with these filters
Parmax Pharma's promoters acquired shares via preferential allotment. This filing discloses the acquisition of equity stakes by eleven promoter-related entities.
Promoter group members Dhiren Shah and Sunil Shah acquired 22,80,444 equity shares in Parmax Pharma Ltd. The acquisition occurred via a preferential allotment on August 29, 2026.
Parmax Pharma allotted 31.37 lakh equity shares at Rs. 36.50 each and 21.45 lakh convertible warrants to various non-promoter allottees on a preferential basis.
Parmax Pharma received BSE's 'In-Principle' approval for a preferential issuance of 31,37,586 equity shares and 21,45,145 warrants at Rs. 36.50 per unit.
Sunil Chinubhai Shah and others acquired 11,52,450 shares (30.81%) of Parmax Pharma Limited. This off-market purchase via a Share Purchase Agreement increases their collective holding to 58.01%.
Parmax Pharma Ltd increased authorized capital by Rs. 4 Crore to Rs. 10 Crore. New Articles of Association were adopted to align with the Companies Act, 2013.